{"brief_title": "Evaluation of Dose-titration of Pramlintide During Initiation of Therapy in Patients Trying to Improve Glucose Control", "brief_summary": "This is a randomized, triple-blind, placebo-controlled, multicenter study to investigate the safety of pramlintide treatment using pramlintide dose-titration coupled with insulin adjustments in subjects with type 1 diabetes who are actively trying to improve their glycemic control.", "condition": ["Diabetes Mellitus, Type 1"], "intervention_type": ["Drug", "Drug"], "intervention_name": ["Pramlintide acetate", "Placebo"], "description": ["Pramlintide injection will be supplied in 5-mL multidose glass vials with rubber stoppers.", "The placebo injection will be supplied in the same 5-mL multidose glass vials with a rubber stopper."], "arm_group_label": ["Pramlintide Acetate (AC137)", "Placebo"], "criteria": "Inclusion Criteria: - HbA1c value between 7.5-9% - Using multiple daily insulin injections", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "mesh_term": ["Diabetes Mellitus", "Diabetes Mellitus, Type 1", "Pramlintide", "Islet Amyloid Polypeptide"], "id": "NCT00042458"}